Furthermore, MIEF2 (mitochondrial elongation factor 2) increased SREBP1 and SREBP2 by activating ROS/AKT/mTOR signaling to drive the lipid synthesis in ovarian cancer cells.34 Here, SREBF2 is linked to ovarian carcinoma.